P&G Hygiene and Health Care Intrinsic Value
P&G Hygiene and Health Care (PGHH) median intrinsic value is ₹3593.60 from 9 valuation models (range ₹1797–₹6597), vs current price ₹8984.00 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse PGHH promoter holding to track promoter, FII and institutional holdings.
PGHH Valuation Methods Summary — DCF, Graham Number & P/E
P&G Hygiene and Health Care intrinsic value across 9 models vs current price ₹8984.00 — upside/downside and value range per method. For current market price and key ratios, visit P&G Hygiene and Health Care screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹6596.50 | ₹5277.20 - ₹7915.80 | -26.6% | EPS: ₹263.86, Sector P/E: 25x |
| Book Value Method | asset | ₹1796.80 | ₹1617.12 - ₹1976.48 | -80.0% | Book Value/Share: ₹228.48, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹2695.20 | ₹2425.68 - ₹2964.72 | -70.0% | Revenue/Share: ₹1297.58, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹4225.45 | ₹3802.90 - ₹4647.99 | -53.0% | EBITDA: ₹1162.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹3593.60 | ₹2874.88 - ₹4312.32 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹2695.20 | ₹2425.68 - ₹2964.72 | -70.0% | EPS Growth: 10.4%, Fair P/E: 8.4x |
| Growth Adjusted P/E | growth | ₹4801.73 | ₹4321.56 - ₹5281.90 | -46.6% | Revenue Growth: 2.2%, Adj P/E: 18.2x |
| ROE Based Valuation | profitability | ₹4492.00 | ₹4042.80 - ₹4941.20 | -50.0% | ROE: 114.5%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2695.20 | ₹2425.68 - ₹2964.72 | -70.0% | EPS: ₹263.86, BVPS: ₹228.48 |
PGHH Intrinsic Value vs Market Price — All Valuation Models
P&G Hygiene and Health Care fair value range ₹1797–₹6597 vs current market price ₹8984.00 across 9 valuation models. Read PGHH dividend history for the complete payout history and dividend yield track record.
PGHH Intrinsic Value Analysis — Undervalued or Overvalued?
P&G Hygiene and Health Care median intrinsic value ₹3593.60, current price ₹8984.00 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of PGHH?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of P&G Hygiene and Health Care (PGHH) is ₹3593.60 (median value). With the current market price of ₹8984.00, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹1796.80 to ₹6596.50, indicating ₹1796.80 - ₹6596.50.
Is PGHH undervalued or overvalued?
Based on our multi-method analysis, P&G Hygiene and Health Care (PGHH) appears to be trading above calculated value by approximately 60.0%.
PGHH Financial Health — Key Ratios vs Industry Benchmarks
P&G Hygiene and Health Care financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.95 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 114.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.37x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
PGHH Cash Flow Quality — Operating & Free Cash Flow
P&G Hygiene and Health Care operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹593 Cr | ₹576 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹470 Cr | ₹470 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹826 Cr | ₹821 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹573 Cr | ₹560 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹863 Cr | ₹863 Cr | Positive Free Cash Flow | 8/10 |